News and Events
Development of a clinical precision medicine program in ovarian cancer as a paradigm for 21st century tailored health care solutions
Co-PIs: Boris Winterhoff, Obstetrics, Gynecology & Women’s health, Andrew Nelson, Laboratory Medicine & Pathology; Joshua Baller, Supercomputing Institute; Constantin Aliferis, Medicine; Pamala Jacobson, Experimental & Clinical Pharmacology
David joined the Department of Medical Genetics and Genomics at Children's Hospitals and Clinics of Minnesota in August, where he will be working with the department and pharmacy services to implement a clinical pharmacogenomics service across the health-system. He completed his B.S and PharmD at the U of M and has previously worked at St Jude Children's Research Hospital in Memphis, TN and Memorial Sloan - Kettering Cancer Center in New York City.
Highlighting the arrival of three new technologies: Pacific Biosciences Sequel, 10X Genomics Chromium System, and Illumina HiSeq 4000.
In a recent survey designed to measure public attitudes about the Precision Medicine Initiative (PMI) Cohort Program, a majority of respondents expressed willingness to participate in the nationwide research effort. Read more about the National Institutes of Health survey
The research effort that aims to engage 1 million or more U.S. participants to improve our ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics. Read more about the National Institutes of Health award.
Her research focus is for every person who needs medical treatment will receive drugs that work for them. Read more about Pam Jacobson.
The UMN College of Education and Human Development hosted a 3 day conference on precision healthcare and childrens mental health, October 5-7. Read more about the conference.
The National Institutes of Health (NIH) has awarded the first-ever grant dedicated to laying the policy groundwork needed to translate genomic medicine into clinical application. Professor Susan M. Wolf, who holds faculty appointments at the Law School and the University of Minnesota Medical School, is one of three eminent researchers who will lead the three-year, $2 million project, known as LawSeqSM.
The 2020 University of Minnesota Biennial Pharmacogenomics Conference is going virtual! The conference originally scheduled for June has moved to an online format and will take place Sept. 10-11.
Using live lectures from experts (with Q&A sessions), moderated small-group breakout discussions, a virtual exhibit hall and a virtual poster session, "Implementation of Pharmacogenomics into Clinical Care" will provide participants with both general knowledge and best practices to support clinical PGx. Register now through September 9, 2020.
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Conference on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.